Organization
ShaoYang Central Hospital
1 abstract
Abstract
Efficacy and safety of neoadjuvant trastuzumab, pyrotinib, and dalpiciclib without chemotherapy in early-stage HR-negative/HER2-positive breast cancer: An open-label, single-arm phase II trial.Org: The First People's Hospital of Xiangtan City, Xiangtan, ShaoYang Central Hospital,